The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Open accessAbstract
The diverse biological activity of interleukin-6 (IL-6) contributes to the maintenance of homeostasis. Emergent infection or tissue injury induces rapid production of IL-6 and activates host defense through augmentation of acute-phase proteins and immune responses. However, excessive IL-6 production and uncontrolled IL-6 receptor signaling are critical to pathogenesis. Over the years, therapeutic agents targeting IL-6 signaling, such as tocilizumab, a humanized anti-IL-6 receptor antibody, have shown remarkable efficacy for rheumatoid arthritis, Castleman disease, and juvenile idiopathic arthritis, and their efficacy in other diseases is continually being reported. Emerging evidence has demonstrated the benefit of tocilizumab for several types of acute inflammatory diseases, including cytokine storms induced by chimeric antigen receptor T cell therapy and coronavirus disease 2019 (COVID-19). Here, we refocus attention on the biology of IL-6 and summarize the distinct pathological roles of IL-6 signaling in several acute and chronic inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Tocilizumab, a humanized monoclonal antibody, is determined to bind to the IL-6 binding site of both membrane and soluble IL-6R, thus blocking classic, trans-, as well as cluster signaling [84, 85].”
From The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases (2024) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Research works printed but not linked: 6
- 10.1182/blood.V74.1.1.1 · DOI
- Song Q, 2015, Int. J. Clin. Exp. Med., 8, 15458
- 10.1182/blood.V82.4.1120.1120 · DOI · Paper page
- Dasgupta B, 1992, J. Rheumatol., 19, 22
- Wendling D, 1993, J. Rheumatol., 20, 259
- De Benedetti F, 1997, J. Rheumatol., 24, 1403
Cited by
Sorted by citations
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 528
Aliyu, M., Zohora, F. T., Anka, A. U., Ali, K., Maleknia, S., Saffarioun, M., & Azizi, G. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109130 · Cited by 455
The advent of immune stimulating CAFs in cancer
Tsoumakidou, M. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00549-7 · Cited by 192
Wu, Y., Sun, X., Kang, K., Yang, Y., Li, H., Zhao, A., & Niu, T. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01621-x · Cited by 115
The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases
Wang, M.-J., Zhang, H.-L., Chen, F., Guo, X.-J., Liu, Q.-G., & Hou, J. (2024) · Experimental Hematology & Oncology · doi:10.1186/s40164-024-00527-1 · Cited by 84
“Tocilizumab, a humanized monoclonal antibody, is determined to bind to the IL-6 binding site of both membrane and soluble IL-6R, thus blocking classic, trans, as well as cluster signaling [84, 85].”
BackgroundGarcía, A. G., Fernández-Martín, J., & Marhuenda, Á. R. (2022) · Rheumatology · doi:10.1093/rheumatology/keac481 · Cited by 63
Matsumoto, C., Shibata, S., Kishi, T., Morimoto, S., Mogi, M., Yamamoto, K. I., Kobayashi, K., Tanaka, M., Asayama, K., Yamamoto, E., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01145-2 · Cited by 61
Fu, H., Guo, Y., Fang, W., Wang, J., Hu, P., & Shi, J. (2023) · Advanced Science · doi:10.1002/advs.202307094 · Cited by 56
Hashimoto, S., Hashimoto, A., Muromoto, R., Kitai, Y., Oritani, K., & Matsuda, T. (2022) · Cells · doi:10.3390/cells11162618 · Cited by 51
Roles of RNA-binding proteins in immune diseases and cancer
Hashimoto, S., & Kishimoto, T. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.017 · Cited by 49
Self-citationJin, G., Liu, Y., Wang, L., He, Z., Zhao, X., Ma, Y., Jia, Y., Li, Z., Yin, N., & Peng, M. (2024) · Nature Immunology · doi:10.1038/s41590-024-01834-9 · Cited by 51
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs
Swaroop, A. K., Negi, P., Kar, A., Mariappan, E., Natarajan, J., Namboori, P. K. K., & Selvaraj, J. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.12.007 · Cited by 48
Structure of the IL-27 quaternary receptor signaling complex
(2022) · doi:10.7554/elife.78463 · Cited by 44
Osteoarthritis: molecular pathogenesis and potential therapeutic options
Zhang, Y., Han, Y., Sun, Y., Hao, L., Gao, Y., Ye, J., Wang, H., Zhang, T., Liu, Y., & Yang, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02556-6 · Cited by 48
N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Duan, Z., Shi, R., Gao, B., & Cai, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05502-2 · Cited by 47
IL-6 Signaling in Immunopathology: From Basic Biology to Selective Therapeutic Intervention
Schumertl, T., Lokau, J., & Garbers, C. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s485684 · Cited by 45
Perspectives of JAK Inhibitors for Large Vessel Vasculitis
Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.881705 · Cited by 36
Fang, C., Du, L., Gao, S., Chen, Y., Chen, Z., Wu, Z., Li, L., Li, J., Zeng, X., Li, M., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-225630 · Cited by 31
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
Chasov, V. V., Zmievskaya, E., Ganeeva, I., Gilyazova, E., Davletshin, D., Khaliulin, M., Kabwe, E., Davidyuk, Y. N., Valiullina, A., Rizvanov, A. A., et al. (2024) · Antibodies · doi:10.3390/antib13010010 · Cited by 29
Structural insights into IL-6 signaling inhibition by therapeutic antibodies
Wang, M., Chen, L., He, J., Xia, W., Ye, Z., & She, J. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113819 · Cited by 28
Li, Y., Ren, H.-C., & Cao, J.-H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109005 · Cited by 34
Pathogenic role of monocytes/macrophages in large vessel vasculitis
Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859502 · Cited by 25
Ferrini, F., Zeppa, S. D., Fraternale, D., Carrabs, V., Annibalini, G., Verardo, G., Gorassini, A., Albertini, M. C., Ismail, T., Fimognari, C., et al. (2022) · Antioxidants · doi:10.3390/antiox11050860 · Cited by 25
Roles of inflammasomes in viral myocarditis
Xu, J., Zhou, Z., Zheng, Y., Yang, S., Huang, K., & Li, H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1149911 · Cited by 25
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
Li, H., Song, W., Wu, J., Shi, Z., Gao, Y., Li, J. Y., Han, L., Zhang, J., Li, Z., Li, Y., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03040-0 · Cited by 23
Nasonov, E. L., & Feist, E. (2022) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2022-505-518 · Cited by 21
Monocyte/macrophage-mediated venous thrombus resolution
Lü, M.-J., Zhang, J., Nie, Z.-Y., Yan, T., Cao, Y., Zhang, L., & Li, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429523 · Cited by 20
Vasculitogenic T Cells in Large Vessel Vasculitis
Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923582 · Cited by 23
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Chen, R., Shi, Y., Fang, N., Shao, C., Huang, H. F., Pan, R., Xu, Y., Wang, M., Liu, X., Xu, K. L., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03834-y · Cited by 18
Zeng, L., Yu, G., Yang, K., He, Q., Hao, W., Wang, X., Long, Z., Chen, H., Tang, X., & Sun, L. (2024) · Scientific Reports · doi:10.1038/s41598-023-48248-5 · Cited by 19
Tang, Z., Mao, Y., Ruan, P., Li, J., Qiu, X., Meng, Y., Wang, M., Wu, G., Wang, L., & Tan, Y. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29643 · Cited by 18
Xing, J., Jia, J., Zhang, H., Han, H., & Li, Q. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.009 · Cited by 18
Kang, S., Onishi, S., Ling, Z., Inoue, H., Zhang, Y., Chang, H., Zhao, H., Wang, T., Okuzaki, D., Matsuura, H., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315898120 · Cited by 17
Self-citationMinihan, B., McAuliffe, É., Powell, J., Wong, S. L., Wilkie, K., Murphy, C., Maher, A., Power, L. E., O’Connell, N. H., & Dunne, C. P. (2022) · Journal of Hospital Infection · doi:10.1016/j.jhin.2022.04.007 · Cited by 20
Yao, Y., Gao, Z., Pan, Z., Zhong, Y., Qin, L., Zhao, K., Liu, S., Zhang, S., Han, H., Yin, F., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167229 · Cited by 16
Qian, H., Yang, X., Zhang, T.-T., Zou, P., Zhang, Y., Tian, W., Mao, Z., & Wei, J. (2024) · American Journal of Hematology · doi:10.1002/ajh.27198 · Cited by 15
Hadiloo, K., Taremi, S., Safa, S. H., Amidifar, S., & Esmaeilzadeh, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107158 · Cited by 14
Human retinal endothelial cells express functional interleukin-6 receptor
Ferreira, L. B., Ashander, L. M., Appukuttan, B., Ma, Y., Williams, K. A., Best, G., & Smith, J. R. (2023) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-023-00341-6 · Cited by 14
Royaei, M. R., Tahoori, M. T., Bardania, H., Shams, A., & Dehghan, A. M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111617 · Cited by 13
Guan, Y., Zhao, X., Lü, Y., Zhang, Y., Lu, Y., & Wang, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1528865 · Cited by 13
Li, X., Yan, D., Liao, M., Zhang, L., Li, Z., Liu, B., Chen, Y., Zhang, Y., Liu, J., & Li, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1163754 · Cited by 13
The NQR Complex Regulates the Immunomodulatory Function of Bacteroides thetaiotaomicron
Engelhart, M. J., Glowacki, R. W. P., Till, J. M., Harding, C. V., Martens, E. C., & Ahern, P. P. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200892 · Cited by 13
Nasonov, E. L. (2024) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2024-32-54 · Cited by 13
Anemia in elderly rheumatoid arthritis patients: a cohort study
Sun, Z.-J., Shao, H., Liu, H., & Ma, L. (2023) · Archives of Medical Science · doi:10.5114/aoms/172443 · Cited by 12
Role of T cells and cytokines in the pathogenesis of rheumatoid arthritis
Anandan, M., & Narayanan, J. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102278 · Cited by 11
Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab
Feist, E., & Nasonov, E. L. (2023) · touchREVIEWS in RMD · doi:10.17925/rmd.2023.2.1.17 · Cited by 13
Long-COVID-19: the persisting imprint of SARS-CoV-2 infections on the innate immune system
Boes, M. L., & Falter‐Braun, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01717-9 · Cited by 10
Xu, D., Tang, L., Wang, Y., Pan, J., & Su, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30903 · Cited by 10
Chen, X., Shibu, G., Sokolsky, B. A., Soussana, T. N., Fisher, L., Deochand, D. K., Dacic, M., Mantel, I., Ramirez, D. C., Bell, R. D., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adq5091 · Cited by 11
Chen, J., Sun, N., Li, F., Li, H., Tian, J., Zheng, S., Zhang, L., Wang, H., & Luo, Y. (2023) · BioMed Research International · doi:10.1155/2023/1179973 · Cited by 10
The latest advances in the use of biological DMARDs to treat Still’s disease
Cola, I. D., & Ruscitti, P. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2307340 · Cited by 10
Habelrih, T., Ferri, B., Côté, F., Sévigny, J., Augustin, T.-L., Sawaya, K., Lubell, W. D., Olson, D. M., Girard, S., & Chemtob, S. (2024) · Clinics in Perinatology · doi:10.1016/j.clp.2024.02.006 · Cited by 10
Tian, Y., Zhang, J., Wu, L., Zhang, C., Zheng, F., Yang, Y., Lu, G., & Xie, D. (2025) · Biomedicines · doi:10.3390/biomedicines13122945 · Cited by 12
Hashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 9
Wang, M., Li, W., Wang, H., & Song, P. (2024) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-024-01392-7 · Cited by 10
Su, J., Hu, W., Ding, Y., Zhang, P., Li, T.-F., Liu, S., & Xing, L. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03373-y · Cited by 8
Liu, Y., Wang, X., You, M. S., Zheng, M., Yu, M., & Leng, X. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1442214 · Cited by 8
Satapathy, T., Minj, A., & Verma, M. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01767-1 · Cited by 11
Jia, Y., Zhang, K., Shi, M., Guo, D., Yang, P., Bu, X., Chen, J., Wang, A., Xu, T., He, J., et al. (2023) · Translational Stroke Research · doi:10.1007/s12975-023-01161-5 · Cited by 9
Liu, C., Liu, X., Xin, H., & Li, X. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1387210 · Cited by 6
Stepanov, A. A., Malsagova, K. A., Kopylov, A. T., Rudnev, V. R., Karateev, D. E., Markelova, E. I., Лучихина, Е. Л., Borisova, E. E., & Kaysheva, A. L. (2023) · Life · doi:10.3390/life13020596 · Cited by 7
Liang, Y., Qiu, S., Zou, Y., Leung, E. L., & Luo, L. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0556 · Cited by 7
Li, K., Cai, J., Jiang, Z., Meng, Q., Zhao, M., Xiao, H. M., Chen, G., Qiao, C., Luo, L., Yu, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69429-w · Cited by 7
Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century
Nasonov, E. L. (2025) · Terapevticheskii arkhiv · doi:10.26442/00403660.2025.05.203213 · Cited by 6
Blood Inflammatory Markers and Cytokines in COVID‐19 Patients With Bacterial Coinfections
Bi, Q., Zhu, J., Zheng, J., Xu, Q., Chen, J., Zhang, L., & Mu, X. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.70105 · Cited by 6
Factors Associated with Mortality Among Severe Omicron Patients for COVID-19
Wu, S., Liao, G., Mao, J., Yan, H., Chen, J., & Peng, J. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s450504 · Cited by 6
A New IL-6-Inducing Mechanism in Cancer with New Therapeutic Possibilities
Håkansson, L., Dunér, P., Broströmer, E., Gustavsson, B. G., Wettergren, Y., Ghafouri, B., Håkansson, A., & Clinchy, B. (2024) · Cancers · doi:10.3390/cancers16213588 · Cited by 6
Sun, M., Cui, Y., Ma, W., Cui, L., Liang, P., Liang, M., Song, J., Tu, G., Ma, B., Jiang, Y., et al. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.124975 · Cited by 5
Targeting PI3Kγ Pathway for Treating Dengue virus Infection
Santos, F. R. D. S., Valadão, D. F., Bambirra, J. L., Moreira, T. P., de Souza, C. D., Passos, I. B. S., Queiroz‐Junior, C. M., Fagundes, C. T., Teixeira, M. M., Costa, V. V., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107060 · Cited by 5
A novel modulator of IL-6R prevents inflammation-induced preterm birth and improves newborn outcome
Côté, F., Prairie, É., Sierra, E. M., Quiniou, C., Habelrih, T., Xu, W., Ferri, B., Hou, X., Lahaie, I., Côté, N., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00257-9 · Cited by 6
Wang, Z., Geng, H., Zhang, Y., Shao, Y., Li, D., Li, Z., Ma, Y., Zhang, Y., Xi, K., Xue, Z., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.146343 · Cited by 5
Wei, Y., Zhou, S., Zhao, W. H., Chen, Q., Wang, Q.-H., Yu, M., Wei, Y., & Hu, T. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1539448 · Cited by 4
Zhang, Y., Cao, X., Ma, X., Guo, Y., Zhang, T., Wu, L., Yang, Y., Hao, C., Liu, W., & Guo, J. (2025) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.70010 · Cited by 4
The role of interleukin-6 in diabetic retinal disease: pathophysiology and therapeutic targeting
Harlow, R. E. A., Rose‐John, S., Hašková, Z., Fauser, S., & Mesquida, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805665 · Cited by 5
Fu, T., Liu, Y., Jia, H., Yao, L., Zhang, S., & Tian, F. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115098 · Cited by 4
Park, J. B. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001830 · Cited by 4
Lunding, L. P., Weckmann, M., Zissler, U. M., Jakwerth, C. A., Bodenstein‐Sgró, R., Webering, S., Vock, C., Ehlers, J. C., Ceballos, R. A. M. F., Nemani, S. S. P., et al. (2025) · Allergy · doi:10.1111/all.70070 · Cited by 4
Du, S., Cui, Z., Xu, X., Liu, T., & Ye, J. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1656713 · Cited by 4
Sinke, L., van Dongen, J., Delerue, T., Wilson, R., Xia, Y., Beekman, M., Willemsen, G. A. H. M., Gieger, C., Herder, C., Köenig, W., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09520-2 · Cited by 4
Pantović, S., Roganović, M., Slavić, V., & Zvizdojevic, J. M. (2024) · International Journal of Biometeorology · doi:10.1007/s00484-024-02630-8 · Cited by 5
Liu, Y., Yin, X., Xu, D., Lv, Y., Li, Z., Yang, M. H., Yao, Q., Jin, J., Huang, L., Meng, H., et al. (2024) · Therapeutic Advances in Hematology · doi:10.1177/20406207241229584 · Cited by 3
Huecksteadt, T., Myers, E., Aamodt, S., Trivedi, S., & Warren, K. (2024) · Viruses · doi:10.3390/v16030472 · Cited by 3
Chen, Q., Lin, S. J., Wang, S., Huang, X., Liang, L., Lu, J., Xie, T., & Cai, X. (2025) · Immunological Investigations · doi:10.1080/08820139.2025.2542200 · Cited by 3
Kano, N., Miki, T., Uehara, Y., Ori, D., & Kawai, T. (2024) · International Immunology · doi:10.1093/intimm/dxae024 · Cited by 2
The use of tocilizumab in severe COVID-19: A comprehensive review
Milošević, I., & Beronja, B. (2024) · Medicinska istrazivanja · doi:10.5937/medi57-48405 · Cited by 2
Chang, P., Li, R., Wen, J., Liu, G., Jin, F., Yu, Y., Li, Y., Zhang, G., & Wang, T. (2025) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2025.05.001 · Cited by 2
Targeting the Dynamics Between TAMs and CAR‐T Cells in Solid Tumor Therapies
Zhang, X., Zheng, H., Liu, Z.-C., Luo, L., Dong, X., Cui, X., Wu, Y., & Chen, L. (2025) · Advanced Science · doi:10.1002/advs.202515700 · Cited by 3
Ma, B., Li, Y., Zhang, J., Fu, Y., & Cao, H. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060695 · Cited by 2
Sugimoto, K., Watanabe, R., Fujita, Y., Fujii, T., Onishi, A., Nozaki, Y., Itami, T., Ebina, K., Etani, Y., Yamada, H., et al. (2026) · Lara D. Veeken · doi:10.1093/rheumatology/keag498 · Cited by 2
Zheng, Z., Lei, J., Chang, J., Yi, X.-X., Zhou, G., & Chen, J. (2024) · Natural Product Communications · doi:10.1177/1934578x241239843 · Cited by 2
Castleman Disease—Still More Questions than Answers: A Case Report and Review of the Literature
Sikora, M., Dąbrowska-Leonik, N., Buda, P., Wolska‐Kuśnierz, B., Jahnz‐Różyk, K., Pac, M., & Więsik–Szewczyk, E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082799 · Cited by 3
Watanabe, R., Murakami, K., Fujisaki, T., Ito, H., Murata, K., Yamamoto, W., Fujii, T., Onizawa, H., Ōnishi, A., Tanaka, M., et al. (2023) · Immunological Medicine · doi:10.1080/25785826.2023.2170384 · Cited by 2
In, I. I., & Deng, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24818 · Cited by 2
COVID‐19 hospitalization with later long COVID in a person with Down syndrome
Amin, M. A., Khan, I. I., Nahin, S., Bonna, A. S., Afrin, S., & Hawlader, M. D. H. (2022) · Clinical Case Reports · doi:10.1002/ccr3.6425 · Cited by 1
Hargarten, J. C., Ssebambulidde, K., Anjum, S. H., Vaughan, M. J., Xu, J., Song, B., Ganguly, A., Park, Y., Scott, T. L., Hammoud, D. A., et al. (2024) · medRxiv · doi:10.1101/2024.01.18.24301483 · Cited by 2
Pirim, D., Niş, H. F., & Bağcı, F. A. (2024) · Trakya University Journal of Natural Sciences · doi:10.23902/trkjnat.1493225 · Cited by 1
Kadokura, H., Harada, N., Yamaki, S., Hirai, N., Tsukuda, R., Azuma, K., Amagai, Y., Nakamura, D., Yanagitani, K., Taguchi, H., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111189 · Cited by 2
RECK as a Potential Crucial Molecule for the Targeted Treatment of Sepsis
Qin, Y., Liao, S., Sun, J., Ye, H., Li, J., Pan, J., He, J., Xia, Z., & Shao, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s501856 · Cited by 2
Kooshki, A., Yousefi, M., Farmani, R., Kabiri-Rad, H., Nezami, H., Zardast, A., & Saremi, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328311 · Cited by 1
Metadata
- Authors
- Kishimoto, T., & Kang, S.
- Affiliations
- Immunology Frontier Research Center, The University of Osaka (JP)
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2022-04-26
- Volume
- 40
- Issue
- 1
- Pages
- 323-348
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W4210578884
- Cited by
- 140
- References
- 171
- Citations by year
- 2026: 27 · 2025: 29 · 2024: 45 · 2023: 21 · 2022: 18
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Ono Medical Research Foundation
- Senri Life Science Foundation
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Keywords
- interleukin-6, IL-6 signaling, tocilizumab, rheumatoid arthritis, Castleman disease, juvenile idiopathic arthritis, CAR T-cell therapy, cytokine storm, COVID-19 pandemic, acute phase response, inflammatory diseases, IL-6 receptor
- MeSH terms
- COVID-19, Animals, Arthritis, Rheumatoid, Humans, Signal Transduction, Interleukin-6, Immunotherapy, Adoptive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review